On Invalid Date, Icad (NASDAQ: ICAD) reported Q3 2022 earnings per share (EPS) of -$0.15, up 66.67% year over year. Total Icad earnings for the quarter were -$3.90 million. In the same quarter last year, Icad's earnings per share (EPS) was -$0.09.
As of Q4 2022, Icad's earnings has grown year over year. Icad's earnings in the past year totalled -$14.71 million.
What was ICAD's revenue last quarter?
On Invalid Date, Icad (NASDAQ: ICAD) reported Q3 2022 revenue of $6.36 million up 32.1% year over year. In the same quarter last year, Icad's revenue was $9.36 million.
What was ICAD's revenue growth in the past year?
As of Q4 2022, Icad's revenue has grown -19.35% year over year. This is 41.66 percentage points lower than the US Health Information Services industry revenue growth rate of 22.31%. Icad's revenue in the past year totalled $29.26 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.